Strategies to Increase Your Confidence with Buprenorphine Prescribing in Primary Care

An estimated 30-70% of providers with the DEA waiver to treat opioid addiction with buprenorphine do not use it.  The goal of this webinar is to review common problems encountered in buprenorphine prescribing via case vignettes.  Approaches and strategies for these common challenges will be provided.

Recorded June 2, 2016  

PRICE/PURCHASE

ASAM and/or CSAM Members: Free
Non-Member: $25.00

You must register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and choose your purchase option (member/non-member) and click "Add to Cart." 

Credit

This enduring internet activity is jointly provided by the California Society of Addiction Medicine (CSAM) and the California Health Care Foundation. CSAM is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.

CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.

Target Audience

Physicians who are looking to exand their treatment of patients with opioid use disorders using buprenorphine.

Course summary
Available credit: 
  • 1.00 AMA Category 1
Course opens: 
06/09/2016
Course expires: 
06/15/2018
Cost:
$25.00
Rating: 
0

Soraya Azari, MD
Assistant Professor, Department of Medicine, UCSF School of Medicine

Scott Steiger, MD
Assistant Professor, Department of Medicine, UCSF School of Medicine

The presenters and planners of this workshop have no relevant financial relationships to disclose.

Available Credit

  • 1.00 AMA Category 1

Learning Objectives

  1. To review proper patient selection for buprenorphine and be able to educate patients how to do a home induction.
  2. To understand the use of buprenorphine in patients with pain and an opioid use disorder.
  3. To identify those patients with pain and co-occurring opioid use disorders for whom buprenorphine may be a preferred pharmacotherapy as part of a comprehensive management plan.
  4. To develop an approach to concerning behaviors that may arise in the patient taking buprenorphine.
  5. To be able to educate patients who are taking methadone how they, as their primary care physician, will help them transition to buprenorphine.

Accreditation Period

Course opens: 
06/09/2016
Course expires: 
06/15/2018

Price

Cost:
$25.00
Please login or register to take this course.